Cargando…
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model
BACKGROUND: Aggregation of tau proteins is a distinct hallmark of tauopathies and has been a focus of research and clinical trials for Alzheimer’s Disease. Recent reports have pointed towards a toxic effect of soluble or oligomeric tau in the spreading of tau pathology in Alzheimer’s disease. Here w...
Autores principales: | Green, Claudia, Sydow, Astrid, Vogel, Stefanie, Anglada-Huguet, Marta, Wiedermann, Dirk, Mandelkow, Eckhard, Mandelkow, Eva-Maria, Hoehn, Mathias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438042/ https://www.ncbi.nlm.nih.gov/pubmed/30917861 http://dx.doi.org/10.1186/s13024-019-0316-6 |
Ejemplares similares
-
Reversal of Tau-Dependent Cognitive Decay by Blocking Adenosine A1 Receptors: Comparison of Transgenic Mouse Models with Different Levels of Tauopathy
por: Anglada-Huguet, Marta, et al.
Publicado: (2023) -
Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice
por: Anglada‐Huguet, Marta, et al.
Publicado: (2021) -
Anti-aggregant tau mutant promotes neurogenesis
por: Joseph, Maria, et al.
Publicado: (2017) -
Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca(++) dysregulation
por: Decker, Jochen Martin, et al.
Publicado: (2015) -
Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
por: Hochgräfe, Katja, et al.
Publicado: (2015)